<DOC>
	<DOCNO>NCT01662648</DOCNO>
	<brief_summary>The purpose study explore efficacy flexibly dose paliperidone extended-release ( ER ) participant schizophrenia ( psychiatric disorder symptom emotional instability , detachment reality , often delusion hallucination , withdrawal self ) previously unsuccessfully treated oral antipsychotic .</brief_summary>
	<brief_title>Safety , Efficacy Tolerability Study Paliperidone Extended-Release ( ER ) Participants With Schizophrenia</brief_title>
	<detailed_description>This single arm ( one group participant ) , multi-center , 6-month study explore tolerability , safety efficacy flexibly dose paliperidone ER participant schizophrenia previously unsuccessfully treated oral antipsychotic medication . Antipsychotic medication drug helpful treatment psychosis capacity ameliorate think disorder . Unsuccessfully treated mean , despite participant treated adequate dose appropriate oral antipsychotic adequate period time , previous treatment consider unsuccessful due lack efficacy , lack tolerability safety , lack compliance and/or reason . Throughout study investigator adjust dosage participant base individual need . In general , recommend paliperidone ER dose 6 milligram daily . Participants either in- outpatient may take study drug without food . Participants complete 6-month study would like continue eligible enrol extension phase paliperidone ER available .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>Participant diagnose schizophrenia Participant 's previous treatment schizophrenia consider unsuccessful Participant healthy basis physical examination vital sign Women must postmenopausal , surgically sterile , abstinent , , sexually active , agree practice effective method birth control entry throughout study Be willing able fill selfadministered questionnaire Have use clozapine Risperdal CONSTA last month , receive conventional drug use treat psychosis last 3 month Judged high risk adverse event , violence selfharm Inability swallow study medication whole aid water Pregnant breastfeed female History current symptom tardive dyskinesia ( involuntary movement facial muscle tongue )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Paliperidone</keyword>
	<keyword>Paliperidone extended-release ( ER )</keyword>
</DOC>